Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-12-09

AUTHORS

Myunggon Ko, Yun Huang, Anna M. Jankowska, Utz J. Pape, Mamta Tahiliani, Hozefa S. Bandukwala, Jungeun An, Edward D. Lamperti, Kian Peng Koh, Rebecca Ganetzky, X. Shirley Liu, L. Aravind, Suneet Agarwal, Jaroslaw P. Maciejewski, Anjana Rao

ABSTRACT

TET2 is a close relative of TET1, an enzyme that converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. The gene encoding TET2 resides at chromosome 4q24, in a region showing recurrent microdeletions and copy-neutral loss of heterozygosity (CN-LOH) in patients with diverse myeloid malignancies. Somatic TET2 mutations are frequently observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemias (AML) and secondary AML (sAML). We show here that TET2 mutations associated with myeloid malignancies compromise catalytic activity. Bone marrow samples from patients with TET2 mutations displayed uniformly low levels of 5hmC in genomic DNA compared to bone marrow samples from healthy controls. Moreover, small hairpin RNA (shRNA)-mediated depletion of Tet2 in mouse haematopoietic precursors skewed their differentiation towards monocyte/macrophage lineages in culture. There was no significant difference in DNA methylation between bone marrow samples from patients with high 5hmC versus healthy controls, but samples from patients with low 5hmC showed hypomethylation relative to controls at the majority of differentially methylated CpG sites. Our results demonstrate that Tet2 is important for normal myelopoiesis, and suggest that disruption of TET2 enzymatic activity favours myeloid tumorigenesis. Measurement of 5hmC levels in myeloid malignancies may prove valuable as a diagnostic and prognostic tool, to tailor therapies and assess responses to anticancer drugs. More... »

PAGES

839-843

Journal

TITLE

Nature

ISSUE

7325

VOLUME

468

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/nature09586

DOI

http://dx.doi.org/10.1038/nature09586

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028352751

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21057493


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "5-Methylcytosine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biocatalysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Differentiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CpG Islands", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Methylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred C57BL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutant Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ko", 
        "givenName": "Myunggon", 
        "id": "sg:person.0730631665.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730631665.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Yun", 
        "id": "sg:person.0734411741.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734411741.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH", 
          "id": "http://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jankowska", 
        "givenName": "Anna M.", 
        "id": "sg:person.011321210657.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011321210657.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115, USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
            "Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pape", 
        "givenName": "Utz J.", 
        "id": "sg:person.01256405722.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256405722.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tahiliani", 
        "givenName": "Mamta", 
        "id": "sg:person.01145273166.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145273166.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bandukwala", 
        "givenName": "Hozefa S.", 
        "id": "sg:person.01050250345.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050250345.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "An", 
        "givenName": "Jungeun", 
        "id": "sg:person.0661570323.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661570323.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lamperti", 
        "givenName": "Edward D.", 
        "id": "sg:person.07542477467.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07542477467.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koh", 
        "givenName": "Kian Peng", 
        "id": "sg:person.01261521566.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261521566.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH", 
          "id": "http://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganetzky", 
        "givenName": "Rebecca", 
        "id": "sg:person.0750217120.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750217120.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115, USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "X. Shirley", 
        "id": "sg:person.01007325065.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007325065.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA", 
          "id": "http://www.grid.ac/institutes/grid.419234.9", 
          "name": [
            "National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aravind", 
        "givenName": "L.", 
        "id": "sg:person.01106662166.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106662166.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA 02115, USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA 02115, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Agarwal", 
        "givenName": "Suneet", 
        "id": "sg:person.01140173463.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140173463.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH", 
          "id": "http://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maciejewski", 
        "givenName": "Jaroslaw P.", 
        "id": "sg:person.016621257257.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016621257257.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA", 
          "id": "http://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children\u2019s Hospital Boston, Boston, MA 02115 USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rao", 
        "givenName": "Anjana", 
        "id": "sg:person.0607343473.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607343473.23"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/leu.2009.47", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050147090", 
          "https://doi.org/10.1038/leu.2009.47"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2009.59", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001464418", 
          "https://doi.org/10.1038/leu.2009.59"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature09303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028926361", 
          "https://doi.org/10.1038/nature09303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng0709-766", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017575923", 
          "https://doi.org/10.1038/ng0709-766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403818", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034281968", 
          "https://doi.org/10.1038/sj.leu.2403818"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature08514", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001394004", 
          "https://doi.org/10.1038/nature08514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048670152", 
          "https://doi.org/10.1038/ng.391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng.463", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032558981", 
          "https://doi.org/10.1038/ng.463"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2009.37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001528169", 
          "https://doi.org/10.1038/leu.2009.37"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/2413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003781258", 
          "https://doi.org/10.1038/2413"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12-09", 
    "datePublishedReg": "2010-12-09", 
    "description": "TET2 is a close relative of TET1, an enzyme that converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. The gene encoding TET2 resides at chromosome 4q24, in a region showing recurrent microdeletions and copy-neutral loss of heterozygosity (CN-LOH) in patients with diverse myeloid malignancies. Somatic TET2 mutations are frequently observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemias (AML) and secondary AML (sAML). We show here that TET2 mutations associated with myeloid malignancies compromise catalytic activity. Bone marrow samples from patients with TET2 mutations displayed uniformly low levels of 5hmC in genomic DNA compared to bone marrow samples from healthy controls. Moreover, small hairpin RNA (shRNA)-mediated depletion of Tet2 in mouse haematopoietic precursors skewed their differentiation towards monocyte/macrophage lineages in culture. There was no significant difference in DNA methylation between bone marrow samples from patients with high 5hmC versus healthy controls, but samples from patients with low 5hmC showed hypomethylation relative to controls at the majority of differentially methylated CpG sites. Our results demonstrate that Tet2 is important for normal myelopoiesis, and suggest that disruption of TET2 enzymatic activity favours myeloid tumorigenesis. Measurement of 5hmC levels in myeloid malignancies may prove valuable as a diagnostic and prognostic tool, to tailor therapies and assess responses to anticancer drugs.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/nature09586", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2705153", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2454410", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2529282", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2668492", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2634317", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2414269", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2421210", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2528229", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1018957", 
        "issn": [
          "0028-0836", 
          "1476-4687"
        ], 
        "name": "Nature", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7325", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "468"
      }
    ], 
    "keywords": [
      "acute myeloid leukemia", 
      "bone marrow samples", 
      "chronic myelomonocytic leukemia", 
      "marrow samples", 
      "myeloid malignancies", 
      "TET2 mutations", 
      "myelodysplastic syndrome", 
      "healthy controls", 
      "myeloproliferative neoplasms", 
      "secondary acute myeloid leukemia", 
      "MDS/MPN overlap syndromes", 
      "overlap syndrome", 
      "secondary AML", 
      "small hairpin RNA", 
      "myelomonocytic leukemia", 
      "myeloid leukemia", 
      "prognostic tool", 
      "impaired hydroxylation", 
      "patients", 
      "copy-neutral loss", 
      "malignancy", 
      "macrophage lineage", 
      "myeloid cancers", 
      "normal myelopoiesis", 
      "hairpin RNA", 
      "significant differences", 
      "mutant TET2", 
      "syndrome", 
      "leukemia", 
      "haematopoietic precursors", 
      "TET2", 
      "anticancer drugs", 
      "recurrent microdeletions", 
      "low levels", 
      "chromosome 4q24", 
      "mutations", 
      "CpG sites", 
      "neoplasms", 
      "therapy", 
      "cancer", 
      "control", 
      "DNA methylation", 
      "drugs", 
      "myelopoiesis", 
      "tumorigenesis", 
      "levels", 
      "activity", 
      "microdeletion", 
      "enzymatic activity", 
      "genomic DNA", 
      "samples", 
      "majority", 
      "hypomethylation", 
      "disruption", 
      "response", 
      "DNA", 
      "differentiation", 
      "depletion", 
      "RNA", 
      "relatives", 
      "TET1", 
      "differences", 
      "genes", 
      "loss", 
      "enzyme", 
      "methylation", 
      "hydroxylation", 
      "culture", 
      "close relatives", 
      "heterozygosity", 
      "lineages", 
      "sites", 
      "resides", 
      "results", 
      "tool", 
      "precursors", 
      "region", 
      "measurements", 
      "catalytic activity", 
      "TET2 resides", 
      "diverse myeloid malignancies", 
      "Somatic TET2 mutations", 
      "MPN overlap syndromes", 
      "depletion of Tet2", 
      "mouse haematopoietic precursors", 
      "TET2 enzymatic activity", 
      "myeloid tumorigenesis"
    ], 
    "name": "Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2", 
    "pagination": "839-843", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028352751"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/nature09586"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21057493"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/nature09586", 
      "https://app.dimensions.ai/details/publication/pub.1028352751"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_504.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/nature09586"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature09586'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature09586'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature09586'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature09586'


 

This table displays all metadata directly associated to this object as RDF triples.

387 TRIPLES      22 PREDICATES      141 URIs      123 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/nature09586 schema:about N2b4ccffc31984b24b1e8759d8faed558
2 N2c68a48096d849c5b4683a40cbff6b21
3 N47db8a29a8e64d77815de73f29f67f2a
4 N53680dcf058c4886a3ea60e8ba6da91b
5 N6af8d2708f8b4e45b37cd08ce9f49708
6 N6c41c692b531483f83694880e4e7e22c
7 Na6ae8f1b43fa4b51958d463a0d698680
8 Nac8ce50e24874bb78f1e83928ff09323
9 Nc0b7be3421204bbd9892a816096b6304
10 Nc1d75e06606341fb8e85558ccf25d043
11 Nc6c114d7c8424fdbb5da7b3e8b6bc113
12 Nd52b793fb71248a984c25dd9c54075ea
13 Ndfaaee4838c248b0b9eb88412ef00e20
14 Nec3bb1f36f1d49869b2b7a0b8de60ce3
15 Nedfb3154cd324ee1b13d5f74aee7a6f8
16 Need5d193da154c73820763c2a56c23e1
17 Nf4153bb412c14723916fc1c37c253f68
18 Nf58b6221abb245eda24a647197d66862
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author Na356e12a7cd2485e84c99d2411a7298f
22 schema:citation sg:pub.10.1038/2413
23 sg:pub.10.1038/leu.2009.37
24 sg:pub.10.1038/leu.2009.47
25 sg:pub.10.1038/leu.2009.59
26 sg:pub.10.1038/nature08514
27 sg:pub.10.1038/nature09303
28 sg:pub.10.1038/ng.391
29 sg:pub.10.1038/ng.463
30 sg:pub.10.1038/ng0709-766
31 sg:pub.10.1038/sj.leu.2403818
32 schema:datePublished 2010-12-09
33 schema:datePublishedReg 2010-12-09
34 schema:description TET2 is a close relative of TET1, an enzyme that converts 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. The gene encoding TET2 resides at chromosome 4q24, in a region showing recurrent microdeletions and copy-neutral loss of heterozygosity (CN-LOH) in patients with diverse myeloid malignancies. Somatic TET2 mutations are frequently observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), MDS/MPN overlap syndromes including chronic myelomonocytic leukaemia (CMML), acute myeloid leukaemias (AML) and secondary AML (sAML). We show here that TET2 mutations associated with myeloid malignancies compromise catalytic activity. Bone marrow samples from patients with TET2 mutations displayed uniformly low levels of 5hmC in genomic DNA compared to bone marrow samples from healthy controls. Moreover, small hairpin RNA (shRNA)-mediated depletion of Tet2 in mouse haematopoietic precursors skewed their differentiation towards monocyte/macrophage lineages in culture. There was no significant difference in DNA methylation between bone marrow samples from patients with high 5hmC versus healthy controls, but samples from patients with low 5hmC showed hypomethylation relative to controls at the majority of differentially methylated CpG sites. Our results demonstrate that Tet2 is important for normal myelopoiesis, and suggest that disruption of TET2 enzymatic activity favours myeloid tumorigenesis. Measurement of 5hmC levels in myeloid malignancies may prove valuable as a diagnostic and prognostic tool, to tailor therapies and assess responses to anticancer drugs.
35 schema:genre article
36 schema:inLanguage en
37 schema:isAccessibleForFree true
38 schema:isPartOf N5c952bce7a5d460fa3f5be267d243d12
39 N78d45e0c1a6345c6a809b956fbfbdc00
40 sg:journal.1018957
41 schema:keywords CpG sites
42 DNA
43 DNA methylation
44 MDS/MPN overlap syndromes
45 MPN overlap syndromes
46 RNA
47 Somatic TET2 mutations
48 TET1
49 TET2
50 TET2 enzymatic activity
51 TET2 mutations
52 TET2 resides
53 activity
54 acute myeloid leukemia
55 anticancer drugs
56 bone marrow samples
57 cancer
58 catalytic activity
59 chromosome 4q24
60 chronic myelomonocytic leukemia
61 close relatives
62 control
63 copy-neutral loss
64 culture
65 depletion
66 depletion of Tet2
67 differences
68 differentiation
69 disruption
70 diverse myeloid malignancies
71 drugs
72 enzymatic activity
73 enzyme
74 genes
75 genomic DNA
76 haematopoietic precursors
77 hairpin RNA
78 healthy controls
79 heterozygosity
80 hydroxylation
81 hypomethylation
82 impaired hydroxylation
83 leukemia
84 levels
85 lineages
86 loss
87 low levels
88 macrophage lineage
89 majority
90 malignancy
91 marrow samples
92 measurements
93 methylation
94 microdeletion
95 mouse haematopoietic precursors
96 mutant TET2
97 mutations
98 myelodysplastic syndrome
99 myeloid cancers
100 myeloid leukemia
101 myeloid malignancies
102 myeloid tumorigenesis
103 myelomonocytic leukemia
104 myelopoiesis
105 myeloproliferative neoplasms
106 neoplasms
107 normal myelopoiesis
108 overlap syndrome
109 patients
110 precursors
111 prognostic tool
112 recurrent microdeletions
113 region
114 relatives
115 resides
116 response
117 results
118 samples
119 secondary AML
120 secondary acute myeloid leukemia
121 significant differences
122 sites
123 small hairpin RNA
124 syndrome
125 therapy
126 tool
127 tumorigenesis
128 schema:name Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
129 schema:pagination 839-843
130 schema:productId N47a73bb57e9341979bc3cd1fc0ee79da
131 N866595a167db448d9e2de990554de222
132 Nc608e624511547a3a9277423c6eb0595
133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028352751
134 https://doi.org/10.1038/nature09586
135 schema:sdDatePublished 2021-11-01T18:13
136 schema:sdLicense https://scigraph.springernature.com/explorer/license/
137 schema:sdPublisher N41506a4e1f394912ad257bcb854b1506
138 schema:url https://doi.org/10.1038/nature09586
139 sgo:license sg:explorer/license/
140 sgo:sdDataset articles
141 rdf:type schema:ScholarlyArticle
142 N01a5c04976544166b6f8979e4fe6b2fe rdf:first sg:person.0661570323.86
143 rdf:rest N34477fca588b49c2b3a91810bc22db80
144 N06672d71ea884c67a06f53459bbde7d5 rdf:first sg:person.01106662166.38
145 rdf:rest N2603d201fa57496bb308e5f46e724759
146 N2603d201fa57496bb308e5f46e724759 rdf:first sg:person.01140173463.29
147 rdf:rest N80d226e9178749d1a6b6add4953df46f
148 N2b4ccffc31984b24b1e8759d8faed558 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Biocatalysis
150 rdf:type schema:DefinedTerm
151 N2c68a48096d849c5b4683a40cbff6b21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Mice
153 rdf:type schema:DefinedTerm
154 N2e8720eea58d4d14b3b744d1e98daba7 rdf:first sg:person.011321210657.93
155 rdf:rest Ndfe622c46b8640eb9cf9fe2f4aa4c078
156 N34477fca588b49c2b3a91810bc22db80 rdf:first sg:person.07542477467.40
157 rdf:rest N3d3a441ff3ad46659bae40d0069b5b98
158 N3d3a441ff3ad46659bae40d0069b5b98 rdf:first sg:person.01261521566.10
159 rdf:rest N94301ca22d8449508b25043dfeca734f
160 N41506a4e1f394912ad257bcb854b1506 schema:name Springer Nature - SN SciGraph project
161 rdf:type schema:Organization
162 N47a73bb57e9341979bc3cd1fc0ee79da schema:name doi
163 schema:value 10.1038/nature09586
164 rdf:type schema:PropertyValue
165 N47db8a29a8e64d77815de73f29f67f2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name DNA Methylation
167 rdf:type schema:DefinedTerm
168 N53680dcf058c4886a3ea60e8ba6da91b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Animals
170 rdf:type schema:DefinedTerm
171 N5c952bce7a5d460fa3f5be267d243d12 schema:issueNumber 7325
172 rdf:type schema:PublicationIssue
173 N673e3d691efe42db87dd45200179a434 rdf:first sg:person.01050250345.56
174 rdf:rest N01a5c04976544166b6f8979e4fe6b2fe
175 N6af8d2708f8b4e45b37cd08ce9f49708 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Mutation
177 rdf:type schema:DefinedTerm
178 N6c41c692b531483f83694880e4e7e22c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Cell Line
180 rdf:type schema:DefinedTerm
181 N78d45e0c1a6345c6a809b956fbfbdc00 schema:volumeNumber 468
182 rdf:type schema:PublicationVolume
183 N80d226e9178749d1a6b6add4953df46f rdf:first sg:person.016621257257.57
184 rdf:rest N849ee8773590446294f42f6c983fd6fa
185 N849ee8773590446294f42f6c983fd6fa rdf:first sg:person.0607343473.23
186 rdf:rest rdf:nil
187 N8573aa8c169f42659672cd2d4b22c7c9 rdf:first sg:person.0734411741.30
188 rdf:rest N2e8720eea58d4d14b3b744d1e98daba7
189 N866595a167db448d9e2de990554de222 schema:name dimensions_id
190 schema:value pub.1028352751
191 rdf:type schema:PropertyValue
192 N94301ca22d8449508b25043dfeca734f rdf:first sg:person.0750217120.38
193 rdf:rest Nc272804f98d54a5a8e5bcada7a65422d
194 Na356e12a7cd2485e84c99d2411a7298f rdf:first sg:person.0730631665.32
195 rdf:rest N8573aa8c169f42659672cd2d4b22c7c9
196 Na6ae8f1b43fa4b51958d463a0d698680 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Proto-Oncogene Proteins
198 rdf:type schema:DefinedTerm
199 Nac8ce50e24874bb78f1e83928ff09323 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name 5-Methylcytosine
201 rdf:type schema:DefinedTerm
202 Nc0b7be3421204bbd9892a816096b6304 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name DNA-Binding Proteins
204 rdf:type schema:DefinedTerm
205 Nc1d75e06606341fb8e85558ccf25d043 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Hydroxylation
207 rdf:type schema:DefinedTerm
208 Nc272804f98d54a5a8e5bcada7a65422d rdf:first sg:person.01007325065.71
209 rdf:rest N06672d71ea884c67a06f53459bbde7d5
210 Nc608e624511547a3a9277423c6eb0595 schema:name pubmed_id
211 schema:value 21057493
212 rdf:type schema:PropertyValue
213 Nc6c114d7c8424fdbb5da7b3e8b6bc113 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Mice, Inbred C57BL
215 rdf:type schema:DefinedTerm
216 Nd52b793fb71248a984c25dd9c54075ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Leukemia, Myeloid, Acute
218 rdf:type schema:DefinedTerm
219 Ndf3e7af87f6f408ca85c599e0e6692eb rdf:first sg:person.01145273166.14
220 rdf:rest N673e3d691efe42db87dd45200179a434
221 Ndfaaee4838c248b0b9eb88412ef00e20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
222 schema:name CpG Islands
223 rdf:type schema:DefinedTerm
224 Ndfe622c46b8640eb9cf9fe2f4aa4c078 rdf:first sg:person.01256405722.88
225 rdf:rest Ndf3e7af87f6f408ca85c599e0e6692eb
226 Nec3bb1f36f1d49869b2b7a0b8de60ce3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
227 schema:name Mutant Proteins
228 rdf:type schema:DefinedTerm
229 Nedfb3154cd324ee1b13d5f74aee7a6f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Cell Differentiation
231 rdf:type schema:DefinedTerm
232 Need5d193da154c73820763c2a56c23e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
233 schema:name DNA, Neoplasm
234 rdf:type schema:DefinedTerm
235 Nf4153bb412c14723916fc1c37c253f68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
236 schema:name Humans
237 rdf:type schema:DefinedTerm
238 Nf58b6221abb245eda24a647197d66862 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
239 schema:name Myelodysplastic Syndromes
240 rdf:type schema:DefinedTerm
241 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
242 schema:name Medical and Health Sciences
243 rdf:type schema:DefinedTerm
244 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
245 schema:name Oncology and Carcinogenesis
246 rdf:type schema:DefinedTerm
247 sg:grant.2414269 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
248 rdf:type schema:MonetaryGrant
249 sg:grant.2421210 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
250 rdf:type schema:MonetaryGrant
251 sg:grant.2454410 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
252 rdf:type schema:MonetaryGrant
253 sg:grant.2528229 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
254 rdf:type schema:MonetaryGrant
255 sg:grant.2529282 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
256 rdf:type schema:MonetaryGrant
257 sg:grant.2634317 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
258 rdf:type schema:MonetaryGrant
259 sg:grant.2668492 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
260 rdf:type schema:MonetaryGrant
261 sg:grant.2705153 http://pending.schema.org/fundedItem sg:pub.10.1038/nature09586
262 rdf:type schema:MonetaryGrant
263 sg:journal.1018957 schema:issn 0028-0836
264 1476-4687
265 schema:name Nature
266 schema:publisher Springer Nature
267 rdf:type schema:Periodical
268 sg:person.01007325065.71 schema:affiliation grid-institutes:grid.65499.37
269 schema:familyName Liu
270 schema:givenName X. Shirley
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007325065.71
272 rdf:type schema:Person
273 sg:person.01050250345.56 schema:affiliation grid-institutes:grid.38142.3c
274 schema:familyName Bandukwala
275 schema:givenName Hozefa S.
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050250345.56
277 rdf:type schema:Person
278 sg:person.01106662166.38 schema:affiliation grid-institutes:grid.419234.9
279 schema:familyName Aravind
280 schema:givenName L.
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106662166.38
282 rdf:type schema:Person
283 sg:person.011321210657.93 schema:affiliation grid-institutes:grid.239578.2
284 schema:familyName Jankowska
285 schema:givenName Anna M.
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011321210657.93
287 rdf:type schema:Person
288 sg:person.01140173463.29 schema:affiliation grid-institutes:grid.65499.37
289 schema:familyName Agarwal
290 schema:givenName Suneet
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140173463.29
292 rdf:type schema:Person
293 sg:person.01145273166.14 schema:affiliation grid-institutes:grid.38142.3c
294 schema:familyName Tahiliani
295 schema:givenName Mamta
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145273166.14
297 rdf:type schema:Person
298 sg:person.01256405722.88 schema:affiliation grid-institutes:grid.65499.37
299 schema:familyName Pape
300 schema:givenName Utz J.
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256405722.88
302 rdf:type schema:Person
303 sg:person.01261521566.10 schema:affiliation grid-institutes:grid.38142.3c
304 schema:familyName Koh
305 schema:givenName Kian Peng
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261521566.10
307 rdf:type schema:Person
308 sg:person.016621257257.57 schema:affiliation grid-institutes:grid.239578.2
309 schema:familyName Maciejewski
310 schema:givenName Jaroslaw P.
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016621257257.57
312 rdf:type schema:Person
313 sg:person.0607343473.23 schema:affiliation grid-institutes:grid.38142.3c
314 schema:familyName Rao
315 schema:givenName Anjana
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0607343473.23
317 rdf:type schema:Person
318 sg:person.0661570323.86 schema:affiliation grid-institutes:grid.38142.3c
319 schema:familyName An
320 schema:givenName Jungeun
321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661570323.86
322 rdf:type schema:Person
323 sg:person.0730631665.32 schema:affiliation grid-institutes:grid.38142.3c
324 schema:familyName Ko
325 schema:givenName Myunggon
326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730631665.32
327 rdf:type schema:Person
328 sg:person.0734411741.30 schema:affiliation grid-institutes:grid.38142.3c
329 schema:familyName Huang
330 schema:givenName Yun
331 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734411741.30
332 rdf:type schema:Person
333 sg:person.0750217120.38 schema:affiliation grid-institutes:grid.239578.2
334 schema:familyName Ganetzky
335 schema:givenName Rebecca
336 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750217120.38
337 rdf:type schema:Person
338 sg:person.07542477467.40 schema:affiliation grid-institutes:grid.38142.3c
339 schema:familyName Lamperti
340 schema:givenName Edward D.
341 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07542477467.40
342 rdf:type schema:Person
343 sg:pub.10.1038/2413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003781258
344 https://doi.org/10.1038/2413
345 rdf:type schema:CreativeWork
346 sg:pub.10.1038/leu.2009.37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001528169
347 https://doi.org/10.1038/leu.2009.37
348 rdf:type schema:CreativeWork
349 sg:pub.10.1038/leu.2009.47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050147090
350 https://doi.org/10.1038/leu.2009.47
351 rdf:type schema:CreativeWork
352 sg:pub.10.1038/leu.2009.59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001464418
353 https://doi.org/10.1038/leu.2009.59
354 rdf:type schema:CreativeWork
355 sg:pub.10.1038/nature08514 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001394004
356 https://doi.org/10.1038/nature08514
357 rdf:type schema:CreativeWork
358 sg:pub.10.1038/nature09303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028926361
359 https://doi.org/10.1038/nature09303
360 rdf:type schema:CreativeWork
361 sg:pub.10.1038/ng.391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048670152
362 https://doi.org/10.1038/ng.391
363 rdf:type schema:CreativeWork
364 sg:pub.10.1038/ng.463 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032558981
365 https://doi.org/10.1038/ng.463
366 rdf:type schema:CreativeWork
367 sg:pub.10.1038/ng0709-766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017575923
368 https://doi.org/10.1038/ng0709-766
369 rdf:type schema:CreativeWork
370 sg:pub.10.1038/sj.leu.2403818 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034281968
371 https://doi.org/10.1038/sj.leu.2403818
372 rdf:type schema:CreativeWork
373 grid-institutes:grid.239578.2 schema:alternateName Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH
374 schema:name Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Cleveland, OH
375 rdf:type schema:Organization
376 grid-institutes:grid.38142.3c schema:alternateName Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115 USA
377 schema:name Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115 USA
378 rdf:type schema:Organization
379 grid-institutes:grid.419234.9 schema:alternateName National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA
380 schema:name National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA
381 rdf:type schema:Organization
382 grid-institutes:grid.65499.37 schema:alternateName Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115, USA
383 Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA 02115, USA
384 schema:name Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02115, USA
385 Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, MA 02115 USA
386 Division of Pediatric Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Boston, MA 02115, USA
387 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...